- £363.99m
- £521.14m
- £1.09bn
- 82
- 85
- 94
- 99
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 881 | 806 | 878 | 960 | 1,089 |
Cost of Revenue | |||||
Gross Profit | 206 | 156 | 180 | 196 | 219 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 853 | 812 | 855 | 919 | 1,038 |
Operating Profit | 28.1 | -6.28 | 23.5 | 40.4 | 51.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 20.3 | -15.2 | 16.3 | 34.9 | 46.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17.2 | -12 | 13.1 | 28.5 | 36.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -66.4 | 44.5 | 14.1 | 28.3 | 35.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -66.4 | 44.5 | 14.1 | 28.3 | 35.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.169 | -0.096 | 0.117 | 0.245 | 0.363 |
Dividends per Share |